脂蛋白 (a) 升高对冠状动脉流量储备的影响
Furkan Bolen1, Adem Atici2, Omer Faruk Baycan2
1Cardiology Department, Besni Public Hospital, Besni, Adıyaman, Turkey.
Expert review of cardiovascular therapy
|July 14, 2025
概括
升高的脂蛋白 (a) [Lp(a) ]水平与冠状动脉流量储备 (CFR) 的减少有关,表明心脏功能受损和亚临床动脉样硬化. 降低Lp (a) 可能减轻心血管疾病的风险.
科学领域:
- 心脏病学 心脏病学
- 生物化学 生物化学
- 遗传学 是一个遗传学.
背景情况:
- 脂蛋白 (a) [Lp(a) ]是一种遗传性脂蛋白.
- 升高的Lp (a) 与心血管疾病和动脉样硬化进展有关.
- 亚临床动脉样硬化评估对于心血管风险分层至关重要.
研究的目的:
- 调查Lp (a) 水平升高与亚临床动脉样硬化之间的关联.
- 为了比较高与正常Lp (a) 水平的个体的冠状动脉流量储备 (CFR).
- 要确定Lp(a) 是否影响冠状动脉血管运动功能.
主要方法:
- 一项前性研究,比较了25名患有升高Lp (a) 的患者和30名患有正常Lp (a) 的对照患者.
- 进行了传统的心声回声测量.
- 冠状动脉流量储备 (CFR) 是主要的结果指标.
主要成果:
- 与对照组 (2.5 ± 0.6) 相比,CFR在升高的Lp(a) 组 (2.0 ± 0.5) 中明显较低,p < 0.001.
- 在Lp(a) 水平和CFR之间发现了显著的负相关性 (r: -0.657,p < 0.001).
- 较高的Lp(a) 水平与冠状动脉血管运动功能的降低相关.
结论:
- 升高的Lp (a) 水平与亚临床动脉样硬化有显著的关联.
- 冠状动脉血管运动功能受损与高Lp (a) 相关.
- 向Lp (a) 可能通过解决其在病变发生中的作用来降低动脉样硬化疾病的风险.
更多相关视频
05:07Author Spotlight: Improved Localization and Monitoring of Coronary Flow Reserve Using Modified PLAX View in Mice
Published on: August 25, 2023
1.3K
06:39Ultrasound Based Assessment of Coronary Artery Flow and Coronary Flow Reserve Using the Pressure Overload Model in Mice
Published on: April 13, 2015
15.1K
相关概念视频
01:26Coronary Artery Disease II: Pathophysiology
40
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
40
01:30Coronary Artery Disease I: Introduction
60
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
60
01:26Coronary Artery Disease IV: Preventive Measures
38
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
38
01:26Atherosclerosis III: Management
40
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
40